Strong Q1 Financial Outperformance
Same-property hotel EBITDA increased 27.6% to $82.2M (came in $8.2M above the high end of outlook). Adjusted EBITDA was $73.3M, up 29.5% YoY and $9.3M above the high end. Adjusted FFO per diluted share doubled YoY to $0.32, $0.09 above the high end.
Topline and Revenue Quality Gains
Same-property occupancy rose 550 bps, ADR increased 2.8%, RevPAR increased 11.8%, and total revenue grew 10.1%. Rooms/group/revenue mix was strong: group ADR up 7.4%, food & beverage revenues +7.4%, outlet revenues +10.2%, and banquet/catering +4.8%.
Meaningful Operating Leverage and Expense Control
Same-property total expenses rose only 5.6% while total revenues increased ~10.2%, driving 327 bps of hotel EBITDA margin expansion. On a per occupied room basis, total expenses declined 2.8% and fixed costs declined 3.2%. Food & beverage expenses +3.7%, sales & marketing (ex franchise fees) +3.9%, energy costs declined 2.8%.
Broad-Based Portfolio Strength
Performance was broad across the portfolio: 32 properties exceeded revenue forecast and 34 exceeded GLP forecast. Urban portfolio RevPAR +14.3%, total RevPAR +12.9%, and EBITDA +55.1%. City-over-urban hotels RevPAR +8.7% with a 900 bps occupancy jump; Chicago RevPAR +5.6%.
Standout Market Recoveries (San Francisco & Los Angeles)
San Francisco RevPAR +44.5% and hotel EBITDA more than tripled (+$11.6M). Los Angeles RevPAR +31.5% and occupancy grew >16 points to 74.6%, with LA Q1 same-property EBITDA recovering prior loss.
Improved Balance Sheet Metrics and Liquidity
Net debt-to-EBITDA declined to 5.5x from 5.9x. Ended quarter with $24.6M cash/restricted cash, ~$641M revolver capacity, weighted average interest rate ~4.1%, and ~98% of debt effectively fixed. Repurchased over 400,000 shares at an average price of $12.11.
Normalized Capex and Strategic Rebranding
Invested $11.9M in the quarter; full-year capital investment guidance maintained at $65M–$75M (more normalized run rate supporting discretionary FCF). Completed rebranding of Mondrian Los Angeles to Curio/major-brand franchise at no net cost (franchise key money funded transition).
Raised Full-Year Outlook
Increased 2026 RevPAR and total RevPAR outlook by 75 bps each (RevPAR range moved to ~2.75%–4.75%; total RevPAR ~3%–5%). Now forecasting same-property EBITDA growth of 5.2%–8.6% with a midpoint near ~7% (Q1 $10M hotel EBITDA beat passed into outlook).